Site-Selective and Deuterium-Programmable Electrochemical Synthesis of Deuterated Pharmaceuticals

Authors:

Abstract
Deuterium labeling plays a pivotal role in pharmaceutical development by modulating physicochemical properties and enabling metabolic tracing. However, site-selective and programmable deuteration in amine-containing pharmaceuticals remains a formidable challenge, as it typically requires prefunctionalized and costly deuterated reagents that hamper scalability and practical utility. Here, we report an electrochemical strategy for synthesizing deuterated amine pharmaceuticals using D2O as a cost-effective deuterium source, enabling site selectivity, degree-programmable deuteration, and excellent deuterium incorporation. Central to this approach is the electrochemical conversion of toxic polyhalides into reactive deuterated building blocks in situ, facilitating the efficient synthesis of over 70 deuterated drugs, with selective mono-, di-, and trideuteration at the N-benzyl, N-methyl, O-benzyl, and S-benzyl positions, and broad functional-group tolerance. Collectively, we establish a platform integrating polyhalides valorization with precision isotopic editing for accessing high-value deuterated pharmaceuticals, especially amine-containing drugs bearing common metabolic soft spots such as benzyl and methyl motifs.
Funding Information
  • Natural Science Foundation of Tianjin Municipality (24JCJQJC00210)
  • National Key Research and Development Program of China (2023YFA1507203)
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China (22188101)
  • National Natural Science Foundation of China (22371149)
  • Frontiers Science Center for New Organic Matter, Nankai University (63181206)
  • Tianjin Major Science and Technology Project for National Key Laboratories (25ZXZSSS00370)
  • Haihe Laboratory of Sustainable Chemical Transformations (25HHWCSS00001)

This publication has 73 references indexed in Scilit: